Schedule 13G ownership disclosure

IMMUNOGEN INC

Security class unavailable · CUSIP: 45253H101

Event date: Unavailable

Legacy cover-page extraction is best effort and may not include every reporting person.

Filing-level shares
2,760,341
Percent of class
1.8000%

Amounts are as disclosed in this filing. Schedule type alone does not establish investment intent.

Source: SEC EDGAR filing

Filing metadata

Accession number
0000895421-19-000464
Form type
SC 13G
Filer
ImmunoGen, Inc.
CIK
CIK 855654
Filed
May 09, 2019
Reporting period
—
Description
Schedule 13G beneficial ownership

Explore SEC Filings Hub